Saba Hajazimian

707 total citations
27 papers, 489 citations indexed

About

Saba Hajazimian is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Saba Hajazimian has authored 27 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Saba Hajazimian's work include MicroRNA in disease regulation (3 papers), Curcumin's Biomedical Applications (3 papers) and CRISPR and Genetic Engineering (2 papers). Saba Hajazimian is often cited by papers focused on MicroRNA in disease regulation (3 papers), Curcumin's Biomedical Applications (3 papers) and CRISPR and Genetic Engineering (2 papers). Saba Hajazimian collaborates with scholars based in Iran, Türkiye and United Kingdom. Saba Hajazimian's co-authors include Alireza Isazadeh, Behzad Baradaran, Sina Taefehshokr, Nazila Fathi Maroufi, Pouya Goleij, Behrouz Shademan, Javad Behroozi, Dariush Shanehbandi, Vahid Vahedian and Masoud Maleki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Life Sciences and Journal of Cellular Physiology.

In The Last Decade

Saba Hajazimian

27 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Saba Hajazimian Iran	15	217	99	87	72	64	27	489
Deepti Singh India	15	227 1.0×	66 0.7×	98 1.1×	36 0.5×	66 1.0×	22	493
Zohreh Hojati Iran	13	443 2.0×	125 1.3×	141 1.6×	78 1.1×	68 1.1×	71	706
Peng Lyu China	11	422 1.9×	104 1.1×	122 1.4×	74 1.0×	70 1.1×	30	767
Mohsen Rastegari‐Pouyani Iran	11	172 0.8×	53 0.5×	85 1.0×	34 0.5×	61 1.0×	18	424
Samil Jung South Korea	17	497 2.3×	88 0.9×	83 1.0×	173 2.4×	41 0.6×	34	877
Yu Xiao China	14	300 1.4×	86 0.9×	91 1.0×	26 0.4×	110 1.7×	34	583
Yingyu Lu China	11	268 1.2×	46 0.5×	103 1.2×	55 0.8×	51 0.8×	21	446
Nehru Viji Sankaranarayanan United States	17	373 1.7×	46 0.5×	70 0.8×	59 0.8×	59 0.9×	35	698
Mohammed Sikander United States	12	347 1.6×	133 1.3×	141 1.6×	57 0.8×	49 0.8×	23	562

Countries citing papers authored by Saba Hajazimian

Since Specialization

Citations

This map shows the geographic impact of Saba Hajazimian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saba Hajazimian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saba Hajazimian more than expected).

Fields of papers citing papers by Saba Hajazimian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saba Hajazimian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saba Hajazimian. The network helps show where Saba Hajazimian may publish in the future.

Co-authorship network of co-authors of Saba Hajazimian

This figure shows the co-authorship network connecting the top 25 collaborators of Saba Hajazimian. A scholar is included among the top collaborators of Saba Hajazimian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saba Hajazimian. Saba Hajazimian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Isazadeh, Alireza, Javad Ahmadian Heris, Parviz Shahabi, et al.. (2023). Pattern-recognition receptors (PRRs) in SARS-CoV-2. Life Sciences. 329. 121940–121940. 16 indexed citations

Isazadeh, Alireza, et al.. (2023). Prevalence of Chromosomal Abnormalities in Iranian Patients with Infertility. Archives of Iranian Medicine. 26(2). 110–116. 3 indexed citations

Shademan, Behrouz, et al.. (2022). CRISPR Technology in Gene-Editing-Based Detection and Treatment of SARS-CoV-2. Frontiers in Molecular Biosciences. 8. 772788–772788. 13 indexed citations

Taefehshokr, Sina, Nima Taefehshokr, Afshin Derakhshani, et al.. (2021). The Regulatory Role of Pivotal MicroRNAs in the AKT Signaling Pathway in Breast Cancer. Current Molecular Medicine. 22(3). 263–273. 9 indexed citations

Maroufi, Nazila Fathi, Mohsen Rashidi, Vahid Vahedian, et al.. (2021). Potential Therapeutic Effects of Melatonin Mediate via miRNAs in Cancer. Biochemical Genetics. 60(1). 1–23. 23 indexed citations

Shademan, Behrouz, Pouya Goleij, Saba Hajazimian, et al.. (2021). Enhanced anticancer potency of hydroxytyrosol and curcumin by PLGA‐PAA nano‐encapsulation on PANC‐1 pancreatic cancer cell line. Environmental Toxicology. 36(6). 1043–1051. 34 indexed citations

Isazadeh, Alireza, et al.. (2021). Wharton jelly stem cells inhibits AGS gastric cancer cells through induction of apoptosis and modification of MAPK and NF-κB signaling pathways. Tissue and Cell. 73. 101597–101597. 6 indexed citations

Vahedian, Vahid, Reza R. Zamani, Saba Hajazimian, et al.. (2020). Anti-inflammatory activity of emu oil-based nanofibrous scaffold through downregulation of IL-1, IL-6, and TNF-α pro-inflammatory cytokines. Hormone Molecular Biology and Clinical Investigation. 41(2). 16 indexed citations

Taefehshokr, Sina, Afshin Derakhshani, Nima Taefehshokr, et al.. (2020). Regulatory role of microRNAs in cancer through Hippo signaling pathway. Pathology - Research and Practice. 216(12). 153241–153241. 17 indexed citations

10.

Hajazimian, Saba, et al.. (2020). Human Wharton’s jelly stem cells inhibit endometriosis through apoptosis induction. Reproduction. 159(5). 549–558. 26 indexed citations

11.

Taefehshokr, Sina, Nima Taefehshokr, Nima Hemmat, et al.. (2020). The pivotal role of MicroRNAs in glucose metabolism in cancer. Pathology - Research and Practice. 217. 153314–153314. 19 indexed citations

12.

Maroufi, Nazila Fathi, Vahid Vahedian, Mohammad‐Reza Rashidi, et al.. (2020). Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment. Pathology - Research and Practice. 216(5). 152919–152919. 47 indexed citations

13.

Maroufi, Nazila Fathi, Saba Hajazimian, Alireza Isazadeh, et al.. (2020). Association of rs1946518 C/A Polymorphism in Promoter Region of Interleukin 18 Gene and Breast Cancer Risk in Iranian Women: A Case-control Study. Iranian Journal of Allergy Asthma and Immunology. 18(6). 671–678. 20 indexed citations

14.

Hajazimian, Saba, et al.. (2019). The effects of cholesterol lowering drugs on vitamin D status in familial hypercholesterolemia patients. 3(4). 5 indexed citations

15.

Isazadeh, Alireza, et al.. (2018). A Novel Homozygous MYO7A Mutation: Case Report. ACTA MEDICA IRANICA. 56(5). 348–350. 3 indexed citations

16.

Hajazimian, Saba, et al.. (2018). Contamination of Chicken Meat With Salmonella spp Distributed in Mahabad City, Iran. SHILAP Revista de lepidopterología. 6(3). 65–68. 9 indexed citations

17.

Mostafazadeh, Mostafa, et al.. (2017). Analysis of cervical lesions for presence of HSV-2 and HPV-16 and HPV-18 in Iranian patients by PCR. Hormone Molecular Biology and Clinical Investigation. 31(3). 13 indexed citations

18.

Hajazimian, Saba, et al.. (2017). Association of Rubella, Cytomegalovirus, and Toxoplasma Infections with Recurrent Miscarriages in Bonab-Iran: A Case-Control Study. Gene Cell and Tissue. In Press(In Press). 7 indexed citations

19.

Isazadeh, Alireza, et al.. (2017). The effects of Factor II (rs1799963) polymorphism on recurrent pregnancy loss in Iranian Azeri women. La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine. 13(1). 37–40. 15 indexed citations

20.

Isazadeh, Alireza, et al.. (2016). The Effect of Factor-XI (rs3756008) Polymorphism on Recurrent Pregnancy Loss in Iranian Azeri Women. Gene Cell and Tissue. 4(1). 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact